GENEVA, Aug. 21 -- PROQR THERAPEUTICS II B.V. filed a patent application (EP2026/053656) for “ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF RENAL DISORDERS”. With publication no. WO/2026/171772, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61P 1/00
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....